PORCELLI, LETIZIA
PORCELLI, LETIZIA
Anti-EGFR monoclonal antibody in cancer treatment: In vitro and in vivo evidence
2011-01-01 Quatrale, A. E.; Petriella, D.; Porcelli, L.; Tommasi, S.; Silvestris, N.; Colucci, G.; Paradiso, A.; Azzariti, A.
BRAFV600E;K601Q metastatic melanoma patient-derived organoids and docking analysis to predict the response to targeted therapy
2022-01-01 Porcelli, Letizia; Di Fonte, Roberta; Pierri, Ciro L; Fucci, Livia; Saponaro, Concetta; Armenio, Andrea; Serratì, Simona; Strippoli, Sabino; Fasano, Rossella; Volpicella, Mariateresa; Daprile, Rossana; Tommasi, Stefania; Ressa, Cosmo M; Guida, Michele; Azzariti, Amalia
CAFs and TGF-β Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine/Nabpaclitaxel in Pancreatic Cancer
2019-01-01 Porcelli, Letizia; Iacobazzi, Rosa Maria; Di Fonte, Roberta; Serrati', Simona; Intini, Angelica; Solimando, Antonio Giovanni; Brunetti, Oronzo; Calabrese, Angela; Leonetti, Francesco; Azzariti, Amalia; Silvestris, Nicola
Circulating extracellular vesicles are monitoring biomarkers of anti-PD1 response and enhancer of tumor progression and immunosuppression in metastatic melanoma
2023-01-01 Serratì, Simona; Di Fonte, Roberta; Porcelli, Letizia; De Summa, Simona; De Risi, Ivana; Fucci, Livia; Ruggieri, Eustachio; Marvulli, TOMMASO MARIA; Strippoli, Sabino; Fasano, Rossella; Rafaschieri, Tania; Guida, Gabriella; Guida, Michele; Azzariti, Amalia
Cyclohexylpiperazine derivative PB28, a σ2 agonist and σ1 antagonist receptor, inhibits cell growth, modulates P-glycoprotein, and synergizes with anthracyclines in breast cancer
2006-01-01 Azzariti, Amalia; Colabufo, Nicola Antonio; Berardi, Francesco; Porcelli, Letizia; Niso, Mauro; Simone, Grazia M.; Perrone, Roberto; Paradiso, Angelo
Detrimental effects of melanocortin-1 receptor (MC1R) variants on the clinical outcomes of BRAF V600 metastatic melanoma patients treated with BRAF inhibitors
2016-01-01 Guida, Michele; Strippoli, Sabino; Ferretta, Anna; Bartolomeo, Nicola; Porcelli, Letizia; Maida, Immacolata; Azzariti, Amalia; Tommasi, Stefania; Grieco, Claudia; Guida, Stefania; Albano, Anna; Lorusso, Vito; Guida, Gabriella
Drug delivery nanovectors based on SPIONS for targeted therapy of hepatocellular carcinoma
2017-01-01 Depalo, N.; Striccoli, M.; Curri, M. L.; Iacobazzi, R. M.; Arduino, Ilaria; Laquintana, V.; Cutrignelli, A.; Lopedota, A.; Franco, M.; Denora, N.; Porcelli, L.; Azzariti, A.; Valente, G.; Fanizza, E.; Villa, S.; Canepa, F.
EGFR tyrosine kinases inhibitors in cancer treatment: in vitro and in vivo evidence
2011-01-01 Quatrale, A. E.; Porcelli, L.; Silvestris, N.; Colucci, G.; Paradiso, A.; Azzariti, A.
Gene Expression Comparison between Alcohol-Exposed Versus Not Exposed Pancreatic Ductal Adenocarcinoma Patients Reveals a Peculiar TGFβ-Related Phenotype: An Exploratory Analysis
2023-01-01 Doronzo, Antonio; Porcelli, Letizia; Marziliano, Donatello; Inglese, Gianfranco; Argentiero, Antonella; Azzariti, Amalia; Solimando, ANTONIO GIOVANNI
Gene Expression Comparison between the Lymph Node-Positive and -Negative Reveals a Peculiar Immune Microenvironment Signature and a Theranostic Role for WNT Targeting in Pancreatic Ductal Adenocarcinoma: A Pilot Study
2019-01-01 Argentiero, Antonella; De Summa, Simona; Di Fonte, Roberta; Iacobazzi, Rosa Maria; Porcelli, Letizia; Da Vià, Matteo; Brunetti, Oronzo; Azzariti, Amalia; Silvestris, Nicola; Solimando, Antonio Giovanni
Hepatic stellate cells induce hepatocellular carcinoma cell resistance to sorafenib through the laminin-332/α3 integrin axis recovery of focal adhesion kinase ubiquitination
2016-01-01 Azzariti, Amalia; Mancarella, Serena; Porcelli, Letizia; Quatrale, ANNA ELISA; Caligiuri, Alessandra; Lupo, Luigi Giovanni; Dituri, Francesco; Giannelli, Gianluigi
Hydroxy-propil-β-cyclodextrin inclusion complexes of two biphenylnicotinamide derivatives: Formulation and anti-proliferative activity evaluation in pancreatic cancer cell models
2020-01-01 Iacobazzi, R. M.; Cutrignelli, A.; Stefanachi, A.; Porcelli, L.; Lopedota, A. A.; Di Fonte, R.; Lopalco, A.; Serrati, S.; Laquintana, V.; Silvestris, N.; Franco, M.; Cellamare, S.; Leonetti, F.; Azzariti, A.; Denora, N.
Long non‐coding rna landscape in prostate cancer molecular subtypes: A feature selection approach
2021-01-01 De Summa, S.; Palazzo, A.; Caputo, M.; Iacobazzi, R. M.; Pilato, B.; Porcelli, L.; Tommasi, S.; Paradiso, A. V.; Azzariti, A.
Microfluidic preparation and in vitro evaluation of iRGD-functionalized solid lipid nanoparticles for targeted delivery of paclitaxel to tumor cells
2021-01-01 Arduino, I.; Liu, Z.; Iacobazzi, R. M.; Lopedota, A. A.; Lopalco, A.; Cutrignelli, A.; Laquintana, V.; Porcelli, L.; Azzariti, A.; Franco, M.; Santos, H. A.; Denora, N.
Microfluidic-assisted preparation of targeted ph-responsive polymeric micelles improves gemcitabine effectiveness in pdac: In vitro insights
2022-01-01 Iacobazzi, R. M.; Arduino, I.; Di Fonte, R.; Lopedota, A. A.; Serrati, S.; Racaniello, G.; Bruno, V.; Laquintana, V.; Lee, B. C.; Silvestris, N.; Leonetti, F.; Denora, N.; Porcelli, L.; Azzariti, A.
New insight into the role of metabolic reprogramming in melanoma cells harboring braf mutations.
2016-01-01 Ferretta, Anna; Maida, Immacolata; Guida, Stefania; Azzariti, A; Porcelli, Letizia; Tommasi, S; Zanna, Paola; Cocco, Tiziana Maria; Guida, M.; Guida, Gabriella
Optimize radiochemotherapy in pancreatic cancer: PARP inhibitors a new therapeutic opportunity
2013-01-01 Porcelli, L.; Quatrale, A. E.; Mantuano, P.; Leo, M. G.; Silvestris, N.; Rolland, J. F.; Carioggia, E.; Lioce, M.; Paradiso, A.; Azzariti, A.
p53 as the main traffic controller of the cell signaling network
2010-01-01 Sebastian, S.; Azzariti, A.; Silvestris, N.; Porcelli, L.; Russo, A.; Tommasino, M.; Paradiso, A.
Potential predictive role of chemotherapy-induced changes of soluble CD40 ligand in untreated advanced pancreatic ductal adenocarcinoma
2016-01-01 Azzariti, A.; Brunetti, O.; Porcelli, L.; Graziano, G.; Iacobazzi, R. M.; Signorile, M.; Scarpa, A.; Lorusso, V.; Silvestris, N.
Probing the interaction between cisplatin and the therapeutic monoclonal antibody trastuzumab
2016-01-01 Lasorsa, Alessia; Losacco, Maurizio; Iacobazzi, ROSA MARIA; Porcelli, Letizia; Azzariti, Amalia; Natile, Giovanni; Arnesano, Fabio
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Anti-EGFR monoclonal antibody in cancer treatment: In vitro and in vivo evidence | 1-gen-2011 | Quatrale, A. E.; Petriella, D.; Porcelli, L.; Tommasi, S.; Silvestris, N.; Colucci, G.; Paradiso, A.; Azzariti, A. | |
| BRAFV600E;K601Q metastatic melanoma patient-derived organoids and docking analysis to predict the response to targeted therapy | 1-gen-2022 | Porcelli, Letizia; Di Fonte, Roberta; Pierri, Ciro L; Fucci, Livia; Saponaro, Concetta; Armenio, Andrea; Serratì, Simona; Strippoli, Sabino; Fasano, Rossella; Volpicella, Mariateresa; Daprile, Rossana; Tommasi, Stefania; Ressa, Cosmo M; Guida, Michele; Azzariti, Amalia | |
| CAFs and TGF-β Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine/Nabpaclitaxel in Pancreatic Cancer | 1-gen-2019 | Porcelli, Letizia; Iacobazzi, Rosa Maria; Di Fonte, Roberta; Serrati', Simona; Intini, Angelica; Solimando, Antonio Giovanni; Brunetti, Oronzo; Calabrese, Angela; Leonetti, Francesco; Azzariti, Amalia; Silvestris, Nicola | |
| Circulating extracellular vesicles are monitoring biomarkers of anti-PD1 response and enhancer of tumor progression and immunosuppression in metastatic melanoma | 1-gen-2023 | Serratì, Simona; Di Fonte, Roberta; Porcelli, Letizia; De Summa, Simona; De Risi, Ivana; Fucci, Livia; Ruggieri, Eustachio; Marvulli, TOMMASO MARIA; Strippoli, Sabino; Fasano, Rossella; Rafaschieri, Tania; Guida, Gabriella; Guida, Michele; Azzariti, Amalia | |
| Cyclohexylpiperazine derivative PB28, a σ2 agonist and σ1 antagonist receptor, inhibits cell growth, modulates P-glycoprotein, and synergizes with anthracyclines in breast cancer | 1-gen-2006 | Azzariti, Amalia; Colabufo, Nicola Antonio; Berardi, Francesco; Porcelli, Letizia; Niso, Mauro; Simone, Grazia M.; Perrone, Roberto; Paradiso, Angelo | |
| Detrimental effects of melanocortin-1 receptor (MC1R) variants on the clinical outcomes of BRAF V600 metastatic melanoma patients treated with BRAF inhibitors | 1-gen-2016 | Guida, Michele; Strippoli, Sabino; Ferretta, Anna; Bartolomeo, Nicola; Porcelli, Letizia; Maida, Immacolata; Azzariti, Amalia; Tommasi, Stefania; Grieco, Claudia; Guida, Stefania; Albano, Anna; Lorusso, Vito; Guida, Gabriella | |
| Drug delivery nanovectors based on SPIONS for targeted therapy of hepatocellular carcinoma | 1-gen-2017 | Depalo, N.; Striccoli, M.; Curri, M. L.; Iacobazzi, R. M.; Arduino, Ilaria; Laquintana, V.; Cutrignelli, A.; Lopedota, A.; Franco, M.; Denora, N.; Porcelli, L.; Azzariti, A.; Valente, G.; Fanizza, E.; Villa, S.; Canepa, F. | |
| EGFR tyrosine kinases inhibitors in cancer treatment: in vitro and in vivo evidence | 1-gen-2011 | Quatrale, A. E.; Porcelli, L.; Silvestris, N.; Colucci, G.; Paradiso, A.; Azzariti, A. | |
| Gene Expression Comparison between Alcohol-Exposed Versus Not Exposed Pancreatic Ductal Adenocarcinoma Patients Reveals a Peculiar TGFβ-Related Phenotype: An Exploratory Analysis | 1-gen-2023 | Doronzo, Antonio; Porcelli, Letizia; Marziliano, Donatello; Inglese, Gianfranco; Argentiero, Antonella; Azzariti, Amalia; Solimando, ANTONIO GIOVANNI | |
| Gene Expression Comparison between the Lymph Node-Positive and -Negative Reveals a Peculiar Immune Microenvironment Signature and a Theranostic Role for WNT Targeting in Pancreatic Ductal Adenocarcinoma: A Pilot Study | 1-gen-2019 | Argentiero, Antonella; De Summa, Simona; Di Fonte, Roberta; Iacobazzi, Rosa Maria; Porcelli, Letizia; Da Vià, Matteo; Brunetti, Oronzo; Azzariti, Amalia; Silvestris, Nicola; Solimando, Antonio Giovanni | |
| Hepatic stellate cells induce hepatocellular carcinoma cell resistance to sorafenib through the laminin-332/α3 integrin axis recovery of focal adhesion kinase ubiquitination | 1-gen-2016 | Azzariti, Amalia; Mancarella, Serena; Porcelli, Letizia; Quatrale, ANNA ELISA; Caligiuri, Alessandra; Lupo, Luigi Giovanni; Dituri, Francesco; Giannelli, Gianluigi | |
| Hydroxy-propil-β-cyclodextrin inclusion complexes of two biphenylnicotinamide derivatives: Formulation and anti-proliferative activity evaluation in pancreatic cancer cell models | 1-gen-2020 | Iacobazzi, R. M.; Cutrignelli, A.; Stefanachi, A.; Porcelli, L.; Lopedota, A. A.; Di Fonte, R.; Lopalco, A.; Serrati, S.; Laquintana, V.; Silvestris, N.; Franco, M.; Cellamare, S.; Leonetti, F.; Azzariti, A.; Denora, N. | |
| Long non‐coding rna landscape in prostate cancer molecular subtypes: A feature selection approach | 1-gen-2021 | De Summa, S.; Palazzo, A.; Caputo, M.; Iacobazzi, R. M.; Pilato, B.; Porcelli, L.; Tommasi, S.; Paradiso, A. V.; Azzariti, A. | |
| Microfluidic preparation and in vitro evaluation of iRGD-functionalized solid lipid nanoparticles for targeted delivery of paclitaxel to tumor cells | 1-gen-2021 | Arduino, I.; Liu, Z.; Iacobazzi, R. M.; Lopedota, A. A.; Lopalco, A.; Cutrignelli, A.; Laquintana, V.; Porcelli, L.; Azzariti, A.; Franco, M.; Santos, H. A.; Denora, N. | |
| Microfluidic-assisted preparation of targeted ph-responsive polymeric micelles improves gemcitabine effectiveness in pdac: In vitro insights | 1-gen-2022 | Iacobazzi, R. M.; Arduino, I.; Di Fonte, R.; Lopedota, A. A.; Serrati, S.; Racaniello, G.; Bruno, V.; Laquintana, V.; Lee, B. C.; Silvestris, N.; Leonetti, F.; Denora, N.; Porcelli, L.; Azzariti, A. | |
| New insight into the role of metabolic reprogramming in melanoma cells harboring braf mutations. | 1-gen-2016 | Ferretta, Anna; Maida, Immacolata; Guida, Stefania; Azzariti, A; Porcelli, Letizia; Tommasi, S; Zanna, Paola; Cocco, Tiziana Maria; Guida, M.; Guida, Gabriella | |
| Optimize radiochemotherapy in pancreatic cancer: PARP inhibitors a new therapeutic opportunity | 1-gen-2013 | Porcelli, L.; Quatrale, A. E.; Mantuano, P.; Leo, M. G.; Silvestris, N.; Rolland, J. F.; Carioggia, E.; Lioce, M.; Paradiso, A.; Azzariti, A. | |
| p53 as the main traffic controller of the cell signaling network | 1-gen-2010 | Sebastian, S.; Azzariti, A.; Silvestris, N.; Porcelli, L.; Russo, A.; Tommasino, M.; Paradiso, A. | |
| Potential predictive role of chemotherapy-induced changes of soluble CD40 ligand in untreated advanced pancreatic ductal adenocarcinoma | 1-gen-2016 | Azzariti, A.; Brunetti, O.; Porcelli, L.; Graziano, G.; Iacobazzi, R. M.; Signorile, M.; Scarpa, A.; Lorusso, V.; Silvestris, N. | |
| Probing the interaction between cisplatin and the therapeutic monoclonal antibody trastuzumab | 1-gen-2016 | Lasorsa, Alessia; Losacco, Maurizio; Iacobazzi, ROSA MARIA; Porcelli, Letizia; Azzariti, Amalia; Natile, Giovanni; Arnesano, Fabio |